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Abstract
Cardiovascular abnormalities are the leading cause of neonatal death among patients with congenital rubella
syndrome (CRS). Although persistence of rubella virus (RV) in fetal endothelium has been repeatedly suggested as a
possible cause of cardiovascular birth defects, evidence of the permissiveness of fetal endothelial cells to RV is
lacking. In this study we evaluated the ability of RV to infect and persist in primary fetal endothelial cells derived from
human umbilical vein (HUVEC). We found that wild type (wt) low passage clinical RV productively infected HUVEC
cultures without producing cytopathology or ultrastructural changes. RV did not inhibit host cell protein synthesis, cell
proliferation, or interfere with the cell cycle. Persistently infected cultures were easily established at low and high
multiplicities of infection (MOI) with both laboratory and wt clinical RV strains. However, synchronous infections of
entire HUVEC monolayers were only observed with clinical RV strains. The release of infectious virions into media
remained at consistently high levels for several subcultures of infected HUVEC. The results indicate that
macrovascular fetal endothelial cells are highly permissive to RV and allow slow persistent RV replication. The
findings provide more evidence for the suggestion that vascular pathologies in CRS are triggered by persistent
rubella virus infection of the endothelium.
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Introduction
Rubella virus (RV) is a single stranded RNA virus of positive
polarity belonging to the genus Rubivirus, in the family
Togaviridae. Postnatal rubella infection causes mild febrile
illness accompanied by maculopapular rash and
lymphadenopathy, while maternal infections during the first
trimester of pregnancy often result in a combination of birth
defects in newborns called congenital rubella syndrome (CRS)
[1]. Although national immunization programs have led to the
elimination or decline in incidence of postnatal rubella and CRS
in many developed countries, approximately 100,000 CRS
cases per year still occur worldwide [2].
RV can establish persistent infection in the developing fetus,
where it continuously replicates and can induce multiple
pathological changes [1,3,4]. However, overall organogenesis
is not usually affected and CRS infants lack gross external and
internal malformations. Even though RV can be isolated from
multiple tissues and organs, only a limited number of cells
show histological evidence of disease [5–7]. A prominent
feature of fetal histopathology is noninflammatory damage to
the endothelium of heart and blood vessels, which includes
focal and obliterative lesions in large blood vessels and cellular
damage in myocardium [6,8–11]. Vascular abnormalities can
lead to a number of clinical manifestations with patent ductus
arteriosus, pulmonary artery stenosis and septal and valve
defects in heart being the most frequent [11,12]. Other clinical
manifestations of congenital rubella, such as general growth
retardation, deafness and neurodegenerative damage, may be
due to vascular insufficiency leading to nutrient deprivation
rather than a result of direct viral damage [4].
Most studies of fetal pathologies using human tissues were
done in the 1960’s, and at that time the lack of molecular
methods and reagents for RV detection precluded the precise
localization of the sites of RV replication and persistence in
congenitally infected fetuses. Nonetheless it was suggested
that vascular pathologies in CRS cases were triggered by the
persistent virus in endothelium [8,13,14]. One line of indirect
evidence was an observed correlation between pathological
changes and presence of RV antigen in placental blood
vessels from CRS affected pregnancies [15]. Another line of
indirect evidence was isolation of RV from diseased ductus
arteriosus and umbilicus of CRS patients [9,16].
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RV is a strictly human pathogen and animal models for CRS
provide little useful information about the pathogenesis of
congenital defects [4,17,18]. Several cell culture models using
both continuous cell lines (e.g. Vero) and primary cells (e.g.
fibroblast) persistently infected with RV have provided some
information about molecular mechanisms of RV persistence
and its effects on cell functions [19–22]. However, the infection
of primary endothelial cell cultures by wtRV has not been
reported to date.
To better understand the molecular mechanisms of vascular
abnormalities in congenital rubella, we developed an
endothelial cell culture model of rubella infection using primary
cultures of fetal endothelial cells derived from human umbilical
vein (HUVEC). We investigated the replicative characteristics
of wtRV strains in HUVEC, the ability of clinical wtRV to
establish persistent infection and the effects of RV infection on
host protein synthesis and on proliferation of endothelial cells.
Materials and Methods
Cells and Viruses
HUVECs (3 different lots, each obtained from 20 pooled
donors, Lonza, Allendale, NJ) were maintained in Endothelial
Cell Growth Medium (Lonza, Allendale, NJ) and grown in flasks
or plates coated with 0.1% gelatin (Sigma-Aldrich, St. Luis,
MO) or fibronectin-coated chamber slides (BD Biosciences,
Franklin Lakes, NJ). HUVECs were used between passages 3
and 5. A549 human lung carcinoma cells (ATCC #CCL-185)
and Vero cells (ATCC #CCL-81) were maintained in Dulbecco's
Modified Eagle Medium (high glucose) (Invitrogen, Carlsbad,
CA) containing 5% FBS (Atlanta Biologicals, Lawrenceville,
GA) supplemented with 50 µg/ml gentamicin (Invitrogen,
Carlsbad, CA). Uninfected cells were cultivated in a humidified
atmosphere with 5% CO2 at 37° C, whereas rubella infected
cells were maintained at 35° C. The laboratory strain F-Therien
was originally obtained from Dr. Frey’s Laboratory. F-Therein is
a derivative of wt clinical strain Therein, which was three times
plaque purified on Vero cells and selected for large plaques
and high virus yield in Vero cells [23]. Clinical isolates RVi
Dezhou.CHN 02 (RV-Dz, genotype 1E) and RVi Seattle.USA
16.00 (RV-WA, genotype 2B) were isolated at the CDC Rubella
Laboratory. All RV strains were propagated in Vero cells and
titered on Vero cells by immunocolorimetric plaque assay [24].
The titer was expressed as plaque forming units (pfu) per ml.
Preparation of High Titer Virus Stocks
Vero cells were grown to high density on FibraCel discs in
single-use 500 ml bottles using a FibraStage system (New
Brunswick Scientific, Edison, NJ) and infected with RV at
MOI=0.01 pfu/cell. Culture media were collected daily from 3
dpi to 9 dpi, centrifuged at 1500 x g for 20 minutes to remove
cell debris and then concentrated by tangential flow filtration
using a Biomax-300 cassette filter (Millipore, Billerica, MA). To
partially purify virus, the concentrated supernatants were
diluted 10-fold with Minimum Essential Medium (Invitrogen,
Carlsbad, CA) and re-concentrated. The procedure was
repeated twice to achieve ~100-fold purification. The titers of
concentrated virus stocks were 2-3x108 pfu/ml. To be used for
a mock control, the spent medium from uninfected Vero cells
were concentrated and purified using the same procedure. The
viral stocks (passage 7) were stored at -80° C in aliquots.
Growth curve analysis
Cells were seeded into 48-well cell culture plates at 1x105
cells/well and infected with RV at MOI of 5 (single-step growth
curve) or 0.05 (multistep growth curve) the following day. After
1-hour adsorption at 35° C, the monolayers were washed 3
times with Hank’s Balanced Salt Solution (HBSS) and overlaid
with 0.5 ml of fresh media. Supernatants and cells were
collected after 10 minutes incubation (0 hpi) and subsequent
samples were collected at later times. Cell lysates were
prepared by adding 0.5 ml media to monolayers followed by 3
cycles of freeze-thaw. Virus was titered on Vero cells in
duplicate.
Cell Cycle Analysis by Flow Cytometry
HUVECs were serum-starved overnight in 0.2% FBS and
then mock-infected or infected with RV-Dz at MOI=10. The
cells were collected at 1 dpi by trypsinization, washed with ice-
cold PBS, resuspended in 200 μL of PBS and added dropwise
into 4 ml of ice-cold 70% ethanol. After overnight fixation (-20°
C) the cells were centrifuged at 800 x g for 10 minutes,
resuspended in 0.5 ml PBS containing 40 µg/ml propidium
iodide (Sigma-Aldrich) and 100 µg/ml RNase (Invitrogen) and
incubated at 37° C for 30 minutes. Total DNA content was
analyzed using a LSRII flow cytometer and FACSDiva 5.01
software (BD Biosciences, Franklin Lakes, NJ).
RNA Extraction and Quantitation
Cells were seeded into 6-well cell culture plates at 4x105
cells/well and mock-infected or infected with RV-Dz at MOI of
5. RNA was isolated using RNAeasy Mini kit (Qiagen)
according to the manufacturer’s instructions. RNA
concentration was measured with NanoDrop
spectrophotometer (Thermo Scientific, Rockford, IL). RT-qPCR
was performed on a 7500 real-time PCR system (Applied
Biosystems, Foster, CA) using Quantifast Multiplex RT-PCR kit
(Qiagen). RNA (100 ng) was amplified using the following
primers and probes: for genomic rubella RNA, RV195F and
RV323R primers and RVP3 probe [25], for the
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene,
GAPDH-F (5’-GAAGGTGAAGGTCGGAGTC-3’) and GAPDH-
R (5’-GAAGATGGTGATGGGATTTC-3’) primers and GAPDH-
P (Cy5-CAAGCTTCCCGTTCTCAGCC-BHQ2) probe. Since
the difference of the slopes of the calibration curves for RV and
GAPDH RNA were less than 0.1, the data were analyzed with
the comparative threshold cycle (ΔΔ CT) method. Data are
presented as a fold change of genomic RNA amount
normalized to GAPDH and relative to the genomic RNA
amount at 4 hpi, when the lowest amount of viral RNA was
detected.
Whole Genome Sequencing
A detailed strategy for a whole genome sequencing of
rubella virus has been described [26].
Rubella Virus Persistence in Endothelial Cells
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Western Blot Analysis
Cell monolayers were washed 3 times with ice-cold PBS and
then proteins were extracted with RIPA buffer (Thermo
Scientific, Rockford, IL) supplemented with Halt protease
cocktail (Thermo Scientific, Rockford, IL). Protein concentration
in the extracts was determined by BCA assay (Thermo
Scientific, Rockford, IL). Equal amounts of total protein (15 μg/
well) for each sample were separated by 4-12% nonreducing
NuPage (Invitrogen, Carlsbad, CA) using MOPS running buffer,
blotted onto nitrocellulose membrane and processed using
SNAP i.d. ® Protein Detection System (Millipore, Billerica, MA)
according to the instrument manual. Briefly, membranes were
blocked in 0.5% milk-PBST (PBS-0.1% Tween-20) for 1 minute
and then incubated with primary antibodies (1:1000 dilution in
0.5% milk-PBST) for 15 minutes. The following rubella-specific
monoclonal antibodies were used: CDC anti- E1 (produced by
the CDC core facility), anti-E2 (Meridian Life Science,
Memphis, TN) and anti-capsid (Abcam, Cambridge, MA). After
washing 3 times with PBST the blots were incubated with
horseradish peroxidase-conjugated anti-mouse IgG (1:1000
dilution in 0.5% milk-PBST) (Thermo Scientific, Rockford, IL)
for 15 minutes. The signal was developed using ECL-plus
detection reagents (GE Healthcare, Piscataway, NJ). After
removing bound antibodies with Restore Western Stripping
Buffer (Thermo Scientific, Rockford, IL) the blots were re-
probed with mouse HRP-conjugated β-actin MAb (Sigma-
Aldrich, St. Louis, MO) to verify equal protein loading.
Immunofluorescence analysis (IFA)
HUVEC cultured on fibronectin-coated chamber slides (BD
Biosciences, Franklin Lakes, NJ) were infected with RV at
MOI=5 or RV-infected HUVECs were plated onto chamber
slides when the infected cultures were passaged. At different
times postinfection the monolayers were rinsed with PBS, fixed
with -20° C methanol for 10 minutes and blocked for 1 hour at
room temperature in 10% normal goat serum-PBST. The cells
were stained with rubella specific MAb or rabbit polyclonal
antibody against von Willebrand factor (vWF) (Sigma-Aldrich,
St. Louis, MO) for 1 hour at room temperature, followed by
incubation with anti-mouse IgG-Alexa488 or anti-rabbit IgG-
Alexa546 antibodies (Molecular probes, Invitrogen) and
counterstaining with DAPI (Molecular probes, Invitrogen). Cells
were mounted with fluorescence mounting medium
(DakoCytomation, Carpinteria, CA). Images were acquired
using a Zeiss fluorescent microscope AxioImager.A1 equipped
with AxioCamMRc5 digital camera. To estimate the percentage
of infected cells, positively stained cells and nuclei were
counted in at least four microscopic fields (~100 cells/field).
Cell proliferation assay
HUVEC were mock-infected or infected with RV-Dz at
MOI=10 in a T25 culture flask. The following day the infected or
mock-infected cells were simultaneously plated into multiple
wells of 6-well plates with a low seeding density of 5x104 cells/
well and cultured for 2-5 days without passaging. Daily, the
mock-infected and infected cells were collected by
trypsinization from duplicate wells and counted using a Scepter
cell counter (Millipore, Billerica, MA). Growth curves were
generated by plotting the number of cells in a well against time
in a culture. After counting, the mock-infected and RV- infected
cells were plated onto chamber slides, and the next day were
immunostained by IFA with capsid MAb (Abcam, Cambridge,
MA) and DAPI (Molecular Probes, Invitrogen) to quantitate
infected cells and mitotic figures. The mitotic indexes were
calculated as % of cells with mitotic figures.
Non-radioactive metabolic labeling of total cellular
proteins
Proteins were labeled using Click-iT L-azidohomoalanine
(AHA) metabolic protein-labeling reagent (Invitrogen, Carlsbad,
CA). At various times postinfection the cell monolayers were
washed with methionine-free RPMI 1640/2% FBS (Invitrogen,
Carlsbad, CA) for 30 minutes and then incubated with
methionine-free RPMI 1640/2% FBS supplemented with 25 µM
AHA for 1.5 hours. The monolayers were washed thrice with
PBS and then proteins were extracted with RIPA buffer and
quantified by BCA assay (Thermo Scientific, Rockford, IL).
Newly synthesized proteins were detected with biotin-alkyne
detection reagent and Click-It protein reaction buffers
(Invitrogen, Carlsbad, CA) according to manufacturer’s
protocol. Briefly, each sample was mixed with biotin-alkyne and
incubated at room temperature for 20 minutes. After extraction
of residual reaction components with chloroform, proteins were
precipitated with methanol, and then equal amounts of proteins
(5 μg/lane for detection of AHA-labeled proteins and β-actin
and 20 μg/lane for capsid detection) were separated by 4-12%
reducing NuPage (Invitrogen, Carlsbad, CA) using MOPS
running buffer and transferred onto a nitrocellulose membrane
and processed manually. The membrane was blocked with 5%
milk-PBST for 1 hour, incubated with streptavidin-poly-HRP
(Vector Labs, Southfield, MI) and then the signal was detected
using ECL-plus detection reagents (GE Healthcare,
Piscataway, NJ).
Transmission electron microscopy (TEM)
Cells were infected with RV at an MOI of 50. Cell culture
pellets were collected at 24 hpi or 17 dpi and fixed with 2.5%
glutaraldehyde. Pellets were postfixed in 1% osmium tetroxide
followed by deionized water rinses and en bloc staining with
4% uranyl acetate. After rinsing the specimen with deionized
water, the pellets were dehydrated in an alcohol series and
infiltrated with acetone. Three ratios of acetone to resin (2:1,
1:1 and 1:2) were used prior to four exchanges of 100% resin
(Epon substitute and Araldite). Polymerization was completed
overnight at 60° C. Thin sections were cut and stained with
uranyl acetate and lead citrate before viewing sections with the
electron microscope (Tecnai Spirit, FEI).
Statistical analyses
The two-way analysis of variance (ANOVA) test with the
Bonferroni posttests was used to compare differences between
virus titers produced by three cell lines at different times
postinfection. A P value of <0.05 was considered significant.
Statistical analyses were performed using the GraphPad Prizm
5 software (GraphPad Software, San Diego, CA).
Rubella Virus Persistence in Endothelial Cells
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Results
RV Replication in Endothelial Cells
Since pathologic lesions are often observed in large elastic
blood vessels of CRS patients including umbilical vein [14], we
used primary cultures of endothelial cells derived from umbilical
vein to examine the susceptibility of fetal endothelial cells to
RV. To ensure that HUVECs retain their specific properties,
cells were always used for experiments before they reached
passage 6 [27]. To evaluate the ability of fetal endothelial cells
to support RV replication, we performed single-step and
multistep growth curve analysis by infecting HUVECs with RV-
Dz at an MOI of 5 and 0.05, respectively, and measuring
accumulation of infectious rubella virions in the culture media.
This isolate was selected based on its genotype (1E), which is
one the most frequently reported globally [28]. For comparison,
we carried out growth assays in Vero cells because RV
replication in this cell line has been investigated in detail
[29,30]. A second comparison cell line A549 was chosen
because of its human origin and its intact IFN system.
RV growth kinetics in HUVECs and Vero cells were
comparable (Figure 1A). The release of newly synthesized
virions was first detected at 24 hpi at both MOIs. Results of
multistep growth analysis (MOI=0.05) showed that RV can
spread effectively in HUVEC monolayer. Results of single step
growth analysis (MOI=5) showed that virus production reached
the maximum value of approximately 5x105pfu/ml by 48 hpi in
both cell types. Given that there were 105 cells/well plated, the
production of extracellular virus in HUVEC and Vero cells was
estimated to be ~5 pfu/cell daily. Initially, RV replication in A549
cells was more efficient than in HUVECs and Vero but
decreased after peaking at 48 hpi at high MOI (Figure 1A).
CPE in a form of cell rounding and detachment from the
monolayer was evident in A549 cells at 72 hpi followed by
massive cell death after 5 dpi, whereas no evident CPE was
observed in HUVEC and Vero (Figure 1D). We were unable to
subculture the infected A549 cells.
RV has been shown to egress with different efficiencies from
different cell lines [31]. To assess RV export from infected
HUVECs, we compared the infectious virus titers in
supernatants and cell lysates. In infected Vero cells, the titer of
extracellular virus was approximately 10% of the intracellular
titer, whereas in both human cell cultures the reverse situation
was observed (Figure 1A-B). These data suggest that egress
of wtRV is more efficient from HUVEC and A549, than from
Vero cells.
The kinetics of genomic RNA replication was studied by
relative quantitation of RV genomic RNA in infected cells by
real-time RT-qPCR (Figure 1C). After the 12-hour eclipse
period, only a 20- to 30-fold increase over the amount of viral
RNA at the eclipse phase was observed at 24 hpi and
thereafter in infected HUVEC. These results suggest that slow
replication kinetics of rubella genomic RNA was mainly
responsible for the low level of virus production in endothelial
cells as it has been shown for other cell types [30,32].
Approximately 10 times more RNA was produced in A549,
which correlated well with higher virus yield relative to HUVEC
(Figure 1A). In HUVEC, RV RNA does not accumulate in the
cytoplasm after synthesis; presumably it is packaged and
continuously released into media, where infectious particles
accumulate. Consequently, infectious titers in the media from
24 to 72 hours post infection were increased more efficiently
than quantities of genomic RNA in cytoplasm at the same time.
Vero cells accumulated 2 logs more intracellular genomic RNA
but only 1 log more infectious particles by 48 hpi compared to
HUVEC (Figure 1B). Intracellular accumulation of large
quantities of genomic RNA has not been observed in Vero cells
infected with laboratory strains adapted to Vero culture [30,32].
These data suggest that Vero cells are less efficient in both
assembly and release of wild type infectious virus than
HUVEC.
Additional evidence of low level of intracellular RV and
efficient export in HUVEC was obtained by transmission
electron microscopy. Very few intracellular and extracellular
viral particles were observed among the infected HUVEC
cultures after 24 hpi and replication complexes were not readily
observable (Figure 1E). By contrast, replication complexes and
larger numbers of intracellular particles were found in Vero
cells (Figure 1F-G), which is in agreement with the results of
our growth experiments and published reports by others [33].
After infection with low passage clinical strains HUVEC did not
exhibit changes in morphology of mitochondria and rough
endoplasmic reticulum or re-distribution of mitochondria, as
observed by others in Vero cells infected with RV lab strains
[34].
We also examined expression of RV structural proteins in
infected HUVEC cultures. E1, E2 and capsid were detectable
by Western blot and IFA as early as at 1 dpi (Figure 2). The
intracellular distribution of the proteins was similar to that seen
in other cell types: E1 and E2 were apparently localized in
trans-Golgi (a tight halo around nuclei), while capsid was
diffusely distributed in cytoplasm (Figure 2B). These data also
indicate that infection of HUVECs with MOI=5 results in
practically synchronous infection: 82%, 91% and 95% of cells
were antigen positive at 1, 2, and 3 dpi, respectively. The
synchronous infection of HUVEC monolayers was also
observed after infection with RV-WA clinical isolate at MOI=5
(data not shown).
Collectively, the data in figures 1 and 2 demonstrate that RV
can productively infect and spread in human fetal endothelial
cells without producing significant cytopathology.
Effects of RV Replication on Global Protein Synthesis
Depending on the cell type, RV has been shown to induce
different degrees of cellular protein synthesis shutoff [35]. To
assess total protein synthesis in HUVEC during RV infection,
metabolic pulse-labeling experiments followed by Western blot
analysis were carried out with the HUVEC cultures infected
with RV-Dz at an MOI of 5. No inhibition of total cellular protein
synthesis was observed in the infected endothelial cultures for
up to 15 dpi (Figure 3A). Since the protein synthesis shutoff
has only been demonstrated in non-human cells (Vero, BHK,
and RK13) [35], it was unclear whether the inability of RV to
interfere with protein synthesis in HUVEC is specific to HUVEC
or is characteristic of human cells. To differentiate between
these possibilities we performed metabolic pulse-labeling
Rubella Virus Persistence in Endothelial Cells
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experiments with A549 infected with RV-Dz at an MOI of 5. The
global protein synthesis was unchanged at 1 dpi, but clearly
reduced by 2 dpi and later times in the infected A549 cells
(Figure 3B). This reduction was not likely due to cell death
Figure 1.  Productive infection of HUVEC with low passage wtRV.  (A–B) Kinetics of RV replication in HUVEC, Vero and A549
cells. Cells were infected with RV-Dz at an MOI of 0.05 or 5. Cell culture supernatants (A) or cell lysates (B) were titered in duplicate
on Vero cells. Data are presented as a mean value +/- standard deviation of two independent experiments each performed in
duplicate. The data were analyzed by two-way ANOVA with the Bonferroni posttests for correcting for multiple comparisons (*,
P<0.05; **, P<0.01; ***, P<0.001). (C) Quantitation of intracellular rubella genomic RNA. HUVEC, Vero and A549 cultures were
infected with RV-Dz at an MOI of 5. Genomic RNA was quantitated by RT-qPCR. GAPDH mRNA was used for normalization in the
comparative threshold cycle method. Data are presented relative to the genomic RNA amount at 4 hpi. The results represent the
mean of at least two independent experiments each done in duplicate. (D) Phase contrast pictures of cells at 5 dpi either mock
infected or RV-Dz infected at MOI=5. Note cytopathic effect of wtRV in A549. (E) Representative images of rubella virions observed
by TEM in HUVEC infected with RV-Dz at MOI=50 at 24 hpi. (F) Representative images of rubella virions and (G) replicative
complexes observed by TEMin Vero cells infected with RV-Dz at MOI=50 at 24 hpi. Inserts represent enlarged images from the
replicative complex and virions that are marked with the red arrows. Bars, 100 nm.
doi: 10.1371/journal.pone.0073014.g001
Rubella Virus Persistence in Endothelial Cells
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because we and others did not observed any CPE or cell death
in A549 infected monolayers at 2 dpi as assessed by IFA
staining for activated caspase-3 (data not shown and [36]).
These data demonstrate that the ability of RV to interfere with
host protein synthesis is not characteristic of all human cell
types. The data also confirm that the recently developed
method of non-radioactive metabolic labeling of newly
synthesized proteins [37] is sensitive enough to detect changes
in protein synthesis in virally infected cells.
Effects of RV Infection on HUVEC Proliferation
To determine the effect of rubella infection on growth of
endothelial cells, we used the cell proliferation assay (see
Material and Methods) to compare growth curves and mitotic
indexes of the mock-infected cultures and cultures infected with
RV-Dz at MOI=10; virtually all cells were positive for RV
antigen at 1 dpi (data not shown). The growth rates of both
cultures were almost identical (Figure 4A). The mitotic indexes
of mock-infected and infected cells were comparable (0.18%
and 0.16%, respectively). Most cells in the infected cultures
remained rubella antigen positive for the duration of the
experiment (5 days) and the proportion of infected cells did not
change indicating RV infected cells proliferate. Moreover, cells
with mitotic figures stained positive for RV capsid (Figure 4B)
demonstrating that infected cells were undergoing mitosis.
These data indicate that RV replication does not interfere with
mitosis and does not inhibit cell proliferation.
We also quantified cells in each phase of the cell cycle in
RV-infected and mock-infected cultures by flow cytometry after
staining cellular DNA with propidium iodide. Both cultures
displayed comparable distributions of cells in each phase
(Figure 4C) supporting the hypothesis that RV does not affect
cell cycle progression in HUVEC.
RV Persistence in Endothelial Cells
To evaluate the ability of RV to persist in endothelial cells,
we monitored virus production in RV-Dz infected HUVEC
cultures, which were maintained without splitting until
senescence (35 dpi). In addition to MOI of 5, HUVECs were
also infected with RV-Dz at MOI of 50 to ensure synchronous
infection of all cells in the monolayer and to match the TEM
experiments. The virus production curves were similar for MOIs
of 5 and 50. Virus production reached a maximum at 2 dpi and
remained at approximately the same level thereafter for both
MOIs (Figure 5A). Capsid protein expression also reached a
maximum at 2 dpi and remained at approximately the same
level up to 14 dpi (Figure 5B). Despite the virus replication, no
differences in cell morphology were observed in the infected
monolayers relative to mock-infected cells at any time during
the experiment (Figure 5C). The numbers of cells in the mock-
infected and infected cultures were comparable at 35 dpi
(Figure 5A) and virtually all cells were E1-antigen positive as
determined by IFA (data not shown). These data further
confirmed the lack of inhibition of HUVEC cell growth by RV
infection. Additionally, no differences in ultrastructure between
RV-Dz- and mock-infected HUVEC cultures were seen by TEM
at 17 dpi (data not shown). The whole genome sequences of
the RV-Dz stock and the viruses isolated from the persistent
cultures at 32 dpi were identical (GenBank acc. # KF201674).
Infection of HUVECs with a different clinical isolate, RV-WA,
at MOI=5 also resulted in persistent culture, in which virus
production was at the same level as in the RV-Dz cultures for
the duration of the experiment and all cells were stained RV-
antigen positive at14dpi (data not shown). Moreover, persistent
cultures were obtained after infection of HUVEC with two
additional passage 2 clinical isolates (genotypes 2B and 1G) at
MOI=0.05. IFA staining for E1 confirmed that all cells in the
persistent cultures were infected (data not shown). Thus, basic
characteristics of persistence with clinical isolates in HUVEC
were shown with a total of four clinical isolates. Experiments
Figure 2.  Expression of viral structural proteins in infected HUVEC.  (A) Kinetics of viral protein synthesis. HUVEC were mock
infected (M) or infected with RV-Dz at an MOI=5. Proteins were separated by 4-12% NuPage gel, either nonreducing (E1, C, β-
actin) or reducing (E2), and then the blots were probed with rubella E1, E2 and C-specific MAb and β-actin MAb.
(B) Spatial distribution of E1, E2 and C proteins in infected cells. HUVECs were infected with RV-Dz at an MOI=5 on chamber slides
and processed for indirect immunofluorescence at 2 dpi using E1, E2 and capsid-specific MAb. Nuclei were counterstained with
DAPI.
doi: 10.1371/journal.pone.0073014.g002
Rubella Virus Persistence in Endothelial Cells
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with two different lots of HUVEC produced similar results (data
not shown). Collectively, the data indicate that fetal endothelial
cells can sustain persistent infection with most wtRV regardless
of MOI.
The ability of RV to persist in endothelial cells during
sequential passages of infected cultures was compared with
that of plaque purified F-Therien, one of the best-characterized
laboratory strains, because the ability of F-Therien to persist in
some cell cultures has been previously demonstrated [21,22].
HUVECs were able to sustain persistent infection with RV-Dz
and F-Therien following three passages when infected at either
high or low MOIs (Figure 6A). Most cells remained positive for
endothelial cell marker vWF (Figure 6C). Unlike clinical
isolates, which infected all cells in a monolayer, F-Therien
infected a small fraction of cells at both MOIs (Figure 6B-C).
Infections with larger virus doses (MOI of 20 and 200) resulted
only in minor increases of a number of F-Therien infected cells
(data not shown). Possibly, plaque purification and the long-
term passage of F-Therein in Vero cells (epithelial origin) has
resulted in changes in endothelial cell tropism as has been
Figure 3.  Lack of global cellular protein synthesis shut-off
in infected HUVEC.  HUVEC and A549 cells were mock
infected or infected with RV-Dz at MOI=5. The cultures were
metabolically pulse-labeled with non-radioactive protein-
labeling reagent AHA at the indicated times postinfection.
Equal amounts (5 μg/lane for detection of AHA-labeled proteins
and β-actin and 20 μg/lane for capsid) of each sample were
separated by 4-12% NuPage and blotted onto nitrocellulose
membrane. (A–B) Blots were probed as described in Material
and Methods to reveal newly synthesized proteins. (C) The
blots were also probed with β-actin MAb to demonstrate equal
protein loading and with capsid MAb to confirm RV infection.
Representative results of two independent experiments are
shown.
doi: 10.1371/journal.pone.0073014.g003
reported for cytomegalovirus (CMV) after in vitro propagation of
clinical strains in fibroblasts [38].
Despite the fact that only about 5% of cells in HUVEC
persistent cultures were infected with F-Therein, the yield of
virus was comparable to RV-Dz infected cultures (Figure 6).
This indicates that F-Therein was able to replicate in HUVEC
with higher yields/cell than that of wt virus, RV-Dz (Figure 6A-
B). Originally, F-Therein strain was plaque-purified and
selected for high replication rates; it produces at least 1 log
more infectious virions in Vero cells than any other rubella
strain studied ( [23]; our unpublished data). Highly efficient
replication of F-Therein was linked to the specific mutations in
the F-Therein genome not found in wt strains and to synthesis
of elevated levels of non-structural replicase proteins [39].
Thus, although F-Therein was able to establish persistent
infection in HUVECs, the characteristics of viral persistence for
F-Therein are different from that of low passage clinical RV
strains making this laboratory strain unsuitable for studying wt
rubella persistence in endothelial cells.
Discussion
In this study we investigated RV persistence in primary fetal
endothelial cells since this cell type is involved in pathogenesis
in congenitally infected fetuses and abnormal endothelium is
found in CRS cases. We found that this system was
significantly different from other systems (e.g. laboratory RV
strains in Vero cells) and may be a good in vitro model for
investigation of molecular mechanisms of RV persistence.
Growth curve experiments combined with detection of rubella
structural proteins and viral particles unequivocally showed that
low passage clinical RV can productively infect and efficiently
spread in primary human endothelial cells without producing
cytopathology. To our knowledge this is the first report
demonstrating endothelial cell tropism of RV. Although other
investigators reported the ability of RV to infect an endothelial
cell line ECV304 [40], this cell line has been proven to be a
cross-contamination with a human bladder cancer cell line
T24/83, which is not of endothelial origin and thus not suited to
study endothelial cell biology [41].
Some characteristics of RV replication in HUVEC including
kinetics of genome replication, structural proteins synthesis and
production of infectious particles were comparable to those
observed by others in commonly used cell lines [30,42].
Additionally, as in other primary cell cultures [19,43,44], RV
infection in endothelial cells had no discernible cytopathic
effect. However, at least four characteristics of RV infection in
endothelial cells differ from those reported for non-endothelial
cell types.
(1) RV infections at MOI≥10 produced synchronously
infected HUVEC cultures in which virtually all cells were RV-
antigen positive at 1 dpi. This is in contrast to other cell types
(e.g. Vero, BHK-21 and human fibroblasts), in which only a
fraction of cells in a culture (10-50%) were infected initially
following virus adsorption (asynchrony), even at high MOIs
[30,35,45,46]. A dependence of rubella replication on a cellular
component present in fluctuating quantities during the cell cycle
was suggested as a possible explanation for asynchronous RV
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infection [30,35]. Asynchrony of RV infection could result from
an inefficient entry of extracellular virions due to either low
receptor density in the cell types previously tested or poor RV-
receptor interactions in cells of non-human origin. In any case,
such models of asynchrony do not seem necessary for wtRV
infection of HUVEC since efficient virus penetration and
synchronous infection was observed.
(2) Infectious RV virions were effectively released from
HUVEC. About one log more infectious RV-Dz was recovered
from extracellular medium compared to intracellular virus
(Figure 1B). In contrast, the titers of cell-associated wtRV were
equal or greater than the viral titers in the culture media in non-
human cell types commonly used to study wtRV replication:
BHK-21, RK-13 [47] and Vero cells (Figure 1 B). Although
efficient RV release from Vero cells has been reported [31], it is
true only for Vero cell-adapted RV strains, not clinical isolates
(our unpublished results). Virus egress was equally efficient
from A549 (Figure 1B), another human cell culture tested here.
Moreover, attempts to identify intracellular virus in tissues of
CRS fetuses were mostly unsuccessful indicating efficient RV
secretion from cells in vivo [48,49]. Taken together these
observations suggest that the wtRV egress mechanism is fine-
tuned to human cells or possibly to particular human cell types.
(3) Infected HUVEC have been observed to secrete
infectious viral particles at 2-3 logs higher titers compared to
other primary cell cultures [20,43,44,50,51]. The difference in
the proportion of infected cells in HUVEC (>95%) and these
other primary cell cultures (ranging from 5 to 70%
[43,44,46,51]) is not sufficient to explain the dramatic
differences in the titers of secreted RV. One explanation is that
Figure 4.  Effects of RV infection on cell proliferation and mitosis.  (A) Growth curves of mock-infected and RV-infected
HUVECs. HUVEC were mock infected or infected with RV-Dz at MOI=10 and then counted daily. The data are results of 2
independent experiments each performed in duplicate. (B) Mitosis in infected HUVEC. At 2 dpi the mock infected and infected
HUVEC (RV-Dz, MOI=10) were immunostained by IFA with capsid MAb and DAPI to quantitate infected cells and mitotic figures.
Mitotic indexes (MI) were calculated as % cells with mitotic figures in two duplicate wells. Note RV-antigen positive mitotic cell in red
circle. (C) Cell cycle analysis of infected HUVEC. Serum-starved HUVECs were mock-infected or infected with RV-Dz at MOI=10.
Histograms of cell cycle analysis at 1 dpi show DNA content of propidium iodide-stained cells by flow cytometry and % of cells in
each phase of the cell cycle. The representative results of two independent experiments are shown.
doi: 10.1371/journal.pone.0073014.g004
Rubella Virus Persistence in Endothelial Cells
PLOS ONE | www.plosone.org 8 August 2013 | Volume 8 | Issue 8 | e73014
some cellular factors essential for RV replication could be
present in abundance in HUVEC but in limited quantities in
other cell types. More efficient secretion of viral particles from
HUVEC might be involved since endothelium is a very active
secretory organ [52].
(4) RV interference with growth properties of HUVEC was
negligible and neither global protein synthesis nor cell
proliferation nor cell cycle was affected in infected HUVEC.
This is in contrast to the numerous studies documenting RV
inhibitory effects on cell growth and proliferation of continuous
cell lines and primary fibroblast cultures derived from fetal
organs [19,20,53–56]. It appears that RV might exert different
effects on cellular growth and metabolism depending on a cell
type it infects.
Since even at high MOI RV infected HUVEC cultures
continue to grow and multiply normally producing consistently
high virus titers, co-adaptation of cells and virus was not
necessary to establish persistent cultures, in which all cells
were productively infected. Persistence of clinical wtRV strains
in endothelial cells is sustained on a single cell level, i.e. the
infected cells survive and transfer viral RNA or infectious
virions into daughter cells after cell division.
The cell/virus cultures systems previously used to study RV
persistence had dramatically different characteristics than that
used here. Since infections of continuous cell lines (e.g. Vero
cells) with lab strains at high MOI are highly cytopathic, low
MOI infections and prolonged serial passage were used to
reach an equilibrium between rates of cell proliferation and cell
killing; less cytopathic mutants persisted thereafter
[21,54,57,58]. In primary cultures, low MOI infections alone
were usually sufficient to establish persistence of lab strains
because of less CPE [20,22,43,44]. The establishment of
persistence of a lab strain in both cell lines and primary
cultures was typically accompanied by cycling of virus titers.
When equilibrium was reached, only a portion of cells were
infected, releasing 2-3 logs fewer viral particles than acutely
infected cultures. It was suggested that rubella persistence in
the previously studied cell types was primarily sustained by a
carrier culture mechanism. Only a fraction of cells in a carrier
culture harbors infectious virus and uninfected cells
proliferation is in balance with death of infected cells and virus
spread [54,57] allowing the virus to persist on a population
level.
Interestingly, we did not observe large fluctuations of virus
titers in HUVEC persistently infected with lab strain F-Therien.
Because the input and persistent wt viruses were identical in
the HUVEC system, some characteristic(s) of HUVEC likely
explains the lack of oscillation in virus titers. One possible
characteristic of the HUVEC cultures resulting in no oscillation
would be a very low but stable sensitivity of the culture to F-
Therein (2-5% of cells infected at any given time). Some other
low cytocidal viruses, such as coxsackievirus B (CVB) or CMV,
can persist in endothelial cell cultures by a carrier culture
mechanism [59–62]. Similar to F-Therein, CVB type 5 can
persist in endothelial cells by infecting 2% of cells in chronic
phase and producing consistent virus titers [60]. Many other
viruses can persistently infect humans and cause disease.
However, the characteristics of persistence can be very
different than that seen in CRS. For example, measles virus
persists in SSPE cases, but in general the persistent state is
maintained in the absence of infectious virus [63,64].
Fetal vascular defects can be caused by a number of factors
including genetic disorders, environmental factors, or
congenital infections. However, it was noted that vascular
pathologies induced by congenital rubella in large blood
vessels are unique and consist of lesions that occurred in the
Figure 5.  RV persistence in HUVEC.  (A) Growth curves of RV-Dz at different MOI. Media were collected every 2-3 days and the
extracellular viruses were titered on Vero cells in duplicate. The adherent cells on the flasks at 35 dpi were collected by
trypsinization into 4 ml of media and counted (cells/ml) using a Scepter cell counter. The representative results of two independent
experiments are shown. (B) Western blot analysis of RV capsid protein expression in persistently infected HUVEC. The blot was re-
probed with β-actin MAb to confirm equal protein loading. (C) Phase contrast images of cells at different times postinfection showing
the lack of CPE in HUVEC persistently infected with RV-Dz strain.
doi: 10.1371/journal.pone.0073014.g005
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inner layer of vascular wall (intima), which otherwise are
structurally preserved without necrosis, calcification or
inflammation [8,14]. Our finding that RV does not cause
cytopathic and ultrastructural changes in endothelial cells
correlates well with this lack of structural damage in fetal
vasculature. Microscopically, vascular lesions in CRS patients
were described as extensive local proliferation of intima
typically found near vascular branching points [8,13,14,65]. It is
presently unknown what cell type proliferates and forms these
Figure 6.  RV persistence after sequential passages of
infected HUVEC.  Cells infected at low and high MOI were
passaged 1:4 at 3, 5 and 9 dpi (indicated by the arrows). (A)
Media were changed every 2-3 days and titer of extracellular
virus was determined by titration on Vero cells. The data are
representative results of 2 independent experiments. (B) After
each passage, the number of the infected cells was determined
by counting E1-positive cells after IFA staining of infected cells
for E1, endothelial cell marker (vWF) and counterstaining for
nuclei (DAPI). (C) The representative results of IFA staining of
the infected cells immediately after the third passage.
doi: 10.1371/journal.pone.0073014.g006
vascular lesions: endothelial cells, which solely constitute
intima, or cells transmigrated from other layers of vascular wall
(e.g. smooth muscle cells). Although we did not observe
enhanced proliferation of endothelial cells in response to
infection in the static cell culture, RV infected cells might
behave differently under conditions of hemodynamic shear
stress. In the cell culture models of atherosclerosis, stimulation
of endothelial cell proliferation was shown to occur in response
to reduced hemodynamic shear stress and turbulent flow, the
conditions found near branching points and vessel curvature
[66,67]. Thus, an investigation of growth characteristics of
infected HUVEC under various flow conditions might provide
some insight into the role of RV infection in lesion formation. A
possible role for smooth muscle cells in this pathological
process should be explored as well.
CMV can also infect and persist in a fetus and cause an
array of congenital defects; many of them are similar to those
in CRS patients (e.g., deafness, growth retardation) [68,69].
However, unlike RV, CMV does not induce vascular
pathologies in a fetus despite the fact that it has an ability to
infect and persist in endothelial cells [70–72]. On the other
hand, CMV was implicated in playing a role in acceleration of
several vascular diseases in adults such as atherosclerosis,
restenosis, and transplant vascular sclerosis. Chronic
perivascular inflammation was shown to be responsible for the
pathological process leading to vascular lesion formation in
these diseases [73–75]. Since inflammation does not play a
role in vascular lesion development in RV-infected fetuses, we
think that molecular mechanisms of RV-induced vascular
disease might be completely different from those occurring with
CMV.
In conclusion, this study clearly shows that fetal endothelial
cells are highly susceptible to rubella virus and support
persistent virus infection providing more evidence for the
suggestion that vascular pathologies in CRS involve persistent
rubella virus infection of the endothelium [8,13,14]. We propose
that HUVEC primary culture persistently infected with clinical
RV strains is a reasonable model to study molecular
mechanisms of rubella persistence.
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